{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:55:31Z","timestamp":1763754931123,"version":"3.45.0"},"reference-count":0,"publisher":"Oncology Nursing Society (ONS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2009,1,1]]},"DOI":"10.1188\/09.cjon.537-542","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T21:05:07Z","timestamp":1254344707000},"page":"537-542","source":"Crossref","is-referenced-by-count":0,"title":["Suboptimal Responses to Imatinib in Chronic Myelogenous Leukemia"],"prefix":"10.1188","volume":"13","author":[{"given":"Sandra","family":"Allen-Bard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2009,9,30]]},"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/N8X1V9MK5K602622.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:49:47Z","timestamp":1763754587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/13\/5\/suboptimal-responses-imatinib-chronic-myelogenous-leukemia"}},"subtitle":["What Are They and How Do They Affect Treatment?"],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,1,1]]}},"alternative-id":["N8X1V9MK5K602622"],"URL":"https:\/\/doi.org\/10.1188\/09.cjon.537-542","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2009,1,1]]}}}